Published in Mediators Inflamm on January 01, 1995
Multimodal holographic microscopy: distinction between apoptosis and oncosis. PLoS One (2015) 1.42
Role of adenylate cyclase-hemolysin in alveolar macrophage apoptosis during Bordetella pertussis infection in vivo. Infect Immun (1998) 1.24
Molecular mechanisms of hepatic apoptosis. Cell Death Dis (2014) 1.21
Differential role of IK and BK potassium channels as mediators of intrinsic and extrinsic apoptotic cell death. Am J Physiol Cell Physiol (2012) 1.05
Reactive oxygen species, apoptosis, antimicrobial peptides and human inflammatory diseases. Pharmaceuticals (Basel) (2015) 0.91
Peroxisome proliferator-activated receptor α protects capillary pericytes in the retina. Am J Pathol (2014) 0.83
Acute mammary and liver transcriptome responses after an intramammary Escherichia coli lipopolysaccharide challenge in postpartal dairy cows. Physiol Rep (2015) 0.79
Increased expression of GAPDH protein is not indicative of nitrosative stress or apoptosis in liver of starved rainbow trout (Oncorhynchus mykiss). Fish Physiol Biochem (2011) 0.78
Effects of nitric oxide on bovine polymorphonuclear functions. Can J Vet Res (2007) 0.77
HIF-mediated innate immune responses: cell signaling and therapeutic implications. Hypoxia (Auckl) (2014) 0.77
Comparative proteomic analysis of liver antioxidant mechanisms in Megalobrama amblycephala stimulated with dietary emodin. Sci Rep (2017) 0.75
High-frequency ultrasound detection of cell death: Spectral differentiation of different forms of cell death in vitro. Oncoscience (2016) 0.75
Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer (1972) 35.74
p53 mutations in human cancers. Science (1991) 31.96
Cell death: the significance of apoptosis. Int Rev Cytol (1980) 24.88
Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature (1992) 17.40
Induction of apoptosis in fibroblasts by c-myc protein. Cell (1992) 16.95
Cancer. p53, guardian of the genome. Nature (1992) 16.36
Participation of p53 protein in the cellular response to DNA damage. Cancer Res (1991) 16.00
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature (1988) 14.66
T cell tolerance by clonal elimination in the thymus. Cell (1987) 13.83
Tissue destruction by neutrophils. N Engl J Med (1989) 13.81
A cell cycle regulator potentially involved in genesis of many tumor types. Science (1994) 13.00
Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature (1992) 12.92
The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell (1991) 10.96
Social controls on cell survival and cell death. Nature (1992) 9.81
Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature (1991) 9.21
Mechanisms and functions of cell death. Annu Rev Cell Biol (1991) 7.76
Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest (1989) 7.60
Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell (1991) 7.40
Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell (1993) 7.16
Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature (1989) 6.70
Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc Natl Acad Sci U S A (1992) 5.94
Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature (1991) 5.80
Programmed death of T cells in HIV-1 infection. Science (1992) 5.63
The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins. Proc Natl Acad Sci U S A (1992) 5.43
Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals. J Exp Med (1992) 5.29
Developmental biology of T cells in T cell-receptor transgenic mice. Annu Rev Immunol (1990) 5.27
Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol (1990) 5.26
Mechanism of antigen-driven selection in germinal centres. Nature (1990) 5.26
Survival of mononuclear phagocytes depends on a lineage-specific growth factor that the differentiated cells selectively destroy. Cell (1982) 5.19
UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol Cell Biol (1984) 4.83
Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene. Nature (1993) 4.81
Cell death and control of cell survival in the oligodendrocyte lineage. Cell (1992) 4.70
Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity. J Exp Med (1993) 4.53
Apoptosis and programmed cell death in immunity. Annu Rev Immunol (1992) 4.47
Apoptosis. Immunol Today (1993) 4.23
Death in embryonic systems. Science (1966) 3.87
A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. J Biol Chem (1993) 3.81
Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature (1990) 3.80
Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis. Immunol Today (1991) 3.79
c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J (1994) 3.58
Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J Biol Chem (1992) 3.48
Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science (1990) 3.46
The role of interleukin-1 in disease. N Engl J Med (1993) 3.45
IL-2 addiction: withdrawal of growth factor activates a suicide program in dependent T cells. Lymphokine Res (1986) 3.11
Interleukin 1 is processed and released during apoptosis. Proc Natl Acad Sci U S A (1991) 3.09
The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis. J Exp Med (1990) 2.89
Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1. J Clin Invest (1991) 2.82
Apoptosis: the biochemistry and molecular biology of programmed cell death. Endocr Rev (1993) 2.76
Death of mature T cells by separate ligation of CD4 and the T-cell receptor for antigen. Nature (1990) 2.73
Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis. Eur J Immunol (1991) 2.71
The cytopathic effect of HIV is associated with apoptosis. Virology (1991) 2.43
Programmed cell death and Bcl-2 protection in the absence of a nucleus. EMBO J (1994) 2.43
Lipopolysaccharide, tumor necrosis factor-alpha, and IL-1 beta prevent programmed cell death (apoptosis) in human peripheral blood monocytes. J Immunol (1991) 2.39
The role of c-myc in cell growth. Curr Opin Genet Dev (1993) 2.17
Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3. J Clin Invest (1988) 2.15
Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes. Immunol Today (1993) 2.09
Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res (1991) 2.08
Cell death mechanisms and the immune system. Immunol Rev (1991) 2.07
Programmed death of autoreactive thymocytes. Nature (1990) 2.01
The genetic program of cell death. Hypothesis and some applications: transformation, carcinogenesis, ageing. J Theor Biol (1982) 1.97
Membrane fusion machinery: insights from synaptic proteins. Cell (1993) 1.96
Regulation of apoptosis in interleukin-3-dependent hemopoietic cells by interleukin-3 and calcium ionophores. EMBO J (1990) 1.94
Resolution of acute inflammation and the role of apoptosis in the tissue fate of granulocytes. Clin Sci (Lond) (1992) 1.91
CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death. Science (1993) 1.74
Susceptibility of soluble and matrix fibronectins to degradation by tissue proteinases, mast cell chymase and cathepsin G. J Biol Chem (1981) 1.66
Interleukin 3 protects murine bone marrow cells from apoptosis induced by DNA damaging agents. J Exp Med (1992) 1.65
Down-regulation of wild-type p53 activity interferes with apoptosis of IL-3-dependent hematopoietic cells following IL-3 withdrawal. EMBO J (1994) 1.64
p53 interacts with p34cdc2 in mammalian cells: implications for cell cycle control and oncogenesis. Oncogene (1990) 1.59
Apoptosis in human eosinophils. Programmed cell death in the eosinophil leads to phagocytosis by macrophages and is modulated by IL-5. J Immunol (1992) 1.56
Apoptosis in interleukin-3-dependent haemopoietic cells. Quantification by two flow cytometric methods. J Immunol Methods (1992) 1.53
Hormonal control of apoptosis in hamster uterine luminal epithelium. Am J Anat (1979) 1.52
Apoptosis of vascular endothelial cells by fibroblast growth factor deprivation. Biochem Biophys Res Commun (1990) 1.44
Thymic selection: a matter of life and death. Immunol Today (1992) 1.43
APO-1 mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: correlation with bcl-2 oncogene expression. Eur J Immunol (1993) 1.39
IL-4 and IL-2 selectively rescue Th cell subsets from glucocorticoid-induced apoptosis. J Immunol (1992) 1.37
IL-3-dependent murine mast cells undergo apoptosis on removal of IL-3. Prevention of apoptosis by c-kit ligand. J Immunol (1993) 1.35
Apoptosis and hematopoiesis in murine fetal liver. Blood (1993) 1.31
Apoptosis in human monocytes: possible role in chronic inflammatory diseases. J Periodontol (1993) 1.26
IL-4 enhances programmed cell death (apoptosis) in stimulated human monocytes. J Immunol (1992) 1.24
Erythropoietin is both a mitogen and a survival factor. Blood (1991) 1.23
The death programme in cultured sympathetic neurones can be suppressed at the posttranslational level by nerve growth factor, cyclic AMP, and depolarization. J Neurochem (1991) 1.22
Rapid acceleration of neutrophil apoptosis by tumor necrosis factor-alpha. Int Immunol (1993) 1.16
Eosinophil hematopoietins antagonize the programmed cell death of eosinophils. Cytokine and glucocorticoid effects on eosinophils maintained by endothelial cell-conditioned medium. J Clin Invest (1991) 1.16
Hematopoietic cytokines inhibit apoptosis induced by transforming growth factor beta 1 and cancer chemotherapy compounds in myeloid leukemic cells. Blood (1992) 1.16
Involvement of inflammatory mediators in macrophage antitumor activity. J Leukoc Biol (1993) 1.15
Apoptosis. Death gets a brake. Nature (1994) 1.15
Apoptosis and DNA fragmentation precede TNF-induced cytolysis in U937 cells. J Cell Biochem (1992) 1.13
Fibroblast growth factor-mediated proliferation of central nervous system precursors depends on endogenous production of insulin-like growth factor I. Proc Natl Acad Sci U S A (1991) 1.11
Apoptosis: a gene-directed programme of cell death. J R Coll Physicians Lond (1992) 1.09
Tumor-suppressor p53 and the cell cycle. Curr Opin Genet Dev (1993) 1.08
Transcriptional transactivation functions localized to the glucocorticoid receptor N terminus are necessary for steroid induction of lymphocyte apoptosis. Mol Cell Biol (1992) 1.07
[Demonstration of an engagement process towards cell death by apoptosis in lymphocytes of HIV infected patients]. C R Acad Sci III (1991) 1.06
Apoptosis and programmed cell death in health and disease. Adv Clin Chem (1994) 1.04
Effects of GM-CSF deprivation on precursors of granulocytes and macrophages. J Cell Physiol (1982) 1.03
Interleukin-4 inhibits apoptotic cell death and loss of the bcl-2 protein in B-chronic lymphocytic leukaemia cells in vitro. Br J Haematol (1993) 1.00
T lymphocytes in infectious mononucleosis. II. Response in vitro to interleukin-2 and establishment of T cell lines. Clin Exp Immunol (1985) 0.93
Nerve growth factor suppresses apoptosis of murine neutrophils. Biochem Biophys Res Commun (1992) 0.90
Characterization of uterine epithelium apoptotic cell death kinetics and regulation by progesterone and RU 486. Am J Pathol (1992) 0.89
Association of polymorphism in the cytochrome CYP2D6 and the efficacy and tolerability of simvastatin. Clin Pharmacol Ther (2001) 2.25
IgG autoantibodies against tissue transglutaminase in relation to antinuclear antibodies. Clin Chem (2001) 2.10
Electrospinning of collagen and elastin for tissue engineering applications. Biomaterials (2005) 2.05
Relative eosinophilia and functional adrenal insufficiency in critically ill patients. Lancet (1999) 1.63
[Cell and disease. III. Apoptosis, the biological counterpart of mitosis]. Ned Tijdschr Geneeskd (1993) 1.40
Patterns of corticosteroid-binding globulin and the free cortisol index during septic shock and multitrauma. Intensive Care Med (2001) 1.26
BBB on chip: microfluidic platform to mechanically and biochemically modulate blood-brain barrier function. Biomed Microdevices (2013) 1.24
Macrophage migration inhibitory factor and hypothalamo-pituitary-adrenal function during critical illness. J Clin Endocrinol Metab (2001) 1.18
In addition to von Willebrand factor and urinary albumin excretion, plasma endothelin is an indicator of endothelial dysfunction in diabetes mellitus. Diabetologia (1993) 1.09
Microfluidic technology in vascular research. J Biomed Biotechnol (2009) 1.06
Differential effects of bisphosphonates on breast cancer cell lines. Cancer Lett (2006) 1.05
Apoptotic cell death kinetics in vitro depend on the cell types and the inducers used. Apoptosis (2004) 1.01
Role of epinephrine and vasopressin in the control of the pituitary-adrenal response to stress. Fed Proc (1985) 0.96
Early features of apoptosis detected by four different flow cytometry assays. Apoptosis (1998) 0.94
Measuring apoptosis in human spermatozoa: a biological assay for semen quality? Fertil Steril (2000) 0.94
Insulin-like growth factor (IGF)-I and IGF binding protein-3 concentrations in fluid from human stimulated follicles. Hum Reprod (1998) 0.92
Maturation of the circadian rhythm of the adrenocortical functions in human neonates and infants. Horm Res (1980) 0.91
Apoptotic cell death in human granulosa-lutein cells: a possible indicator of in vitro fertilization outcome. Fertil Steril (1998) 0.91
Apoptosis: molecular mechanisms and implications for cancer chemotherapy. Pharm World Sci (1997) 0.91
Flexible and elastic porous poly(trimethylene carbonate) structures for use in vascular tissue engineering. Acta Biomater (2009) 0.90
Beta-adrenergic stimulation induces an increase of the plasma levels of immunoreactive alpha-MSH, beta-endorphin, ACTH and of corticosterone. Life Sci (1981) 0.90
Analyzing shear stress-induced alignment of actin filaments in endothelial cells with a microfluidic assay. Biomicrofluidics (2010) 0.89
Follicle-stimulating hormone measured in unextracted urine: a reliable tool for easy assessment of ovarian capacity. Fertil Steril (1998) 0.87
The beta-adrenoceptor-blocking drug propranolol prevents secretion of immunoreactive beta-endorphin and alpha-melanocyte-stimulating hormone in response to certain stress stimuli. Endocrinology (1984) 0.86
Temperature effects on free-thyroxine measurements: analytical and clinical consequences. Clin Chem (1992) 0.86
Beta 3-adrenergic receptor gene polymorphism and type 2 diabetes in a Caucasian population. Diabetes Obes Metab (2001) 0.85
Studies on the prolactin response induced by electroconvulsive therapy in schizophrenics. Acta Psychiatr Scand (1980) 0.85
Apoptosis and proliferation in breast cancer cells, cultured in vitro: effects of SERMs. Climacteric (2005) 0.85
A superfusion system technique for the study of the sites of action of glucocorticoids in the rat hypothalamus-pituitary-adrenal system in vitro. II. Hypothalamus-pituitary cell-adrenal cell superfusion. Endocrinology (1977) 0.85
Apoptosis- and necrosis-inducing potential of cladribine, cytarabine, cisplatin, and 5-fluorouracil in vitro: a quantitative pharmacodynamic model. Cancer Chemother Pharmacol (1998) 0.85
Similar alterations of lymphocyte subpopulations in type I and type II diabetes. Neth J Med (1993) 0.84
Apoptosis: programmed cell death in fetal development. Eur J Obstet Gynecol Reprod Biol (1996) 0.84
Effect of hypothalamus lesions on the presence of CRF-immunoreactive nerve terminals in the median eminence and on the pituitary-adrenal response to stress. Regul Pept (1982) 0.83
Electrospinning collagen and elastin for tissue engineering small diameter blood vessels. J Control Release (2005) 0.83
Cerebrospinal-fluid tau protein and aspartate aminotransferase in Parkinson's disease. Lancet (1998) 0.83
First steps towards tissue engineering of small-diameter blood vessels: preparation of flat scaffolds of collagen and elastin by means of freeze drying. J Biomed Mater Res B Appl Biomater (2006) 0.82
Hsp70- and p53-reponses after heat treatment and/or X-irradiation mediate the susceptibility of hematopoietic cells to undergo apoptosis. Int J Radiat Biol (2008) 0.82
Beta-adrenoceptor activation mediates stress-induced secretion of beta-endorphin-related peptides from intermediate but not anterior pituitary. Nature (1983) 0.82
Apoptosis induced kinetic changes in autofluorescence of cultured HL60 cells-possible application for single cell analysis on chip. Apoptosis (2004) 0.82
Inhibitory action of serotonin on hypothalamus-induced ACTH release. Acta Physiol Acad Sci Hung (1972) 0.81
Endogenous mediators in sepsis and septic shock. Adv Clin Chem (1998) 0.81
Increased plasma levels of immunoreactive beta-endorphin and corticotropin in non-insulin-dependent diabetes. Lancet (1985) 0.81
Bax-mediated mitochondrial membrane permeabilization after heat treatment is caspase-2 dependent. Int J Hyperthermia (2008) 0.81
Sequential occurrence of mitochondrial and plasma membrane alterations, fluctuations in cellular Ca2+ and pH during initial and later phases of cell death. Apoptosis (1999) 0.80
Shear stress induces a transient and VEGFR-2-dependent decrease in the motion of injected particles in endothelial cells. Biorheology (2010) 0.80
Stress-induced secretion of adrenocorticotropin in rats is inhibited by administration of antisera to ovine corticotropin-releasing factor and vasopressin. Endocrinology (1985) 0.80
The low dose (1 microg) ACTH stimulation test for assessment of the hypothalamo-pituitary-adrenal axis. Neth J Med (2000) 0.80
Micral-Test: a qualitative dipstick test for micro-albuminuria. Diabetes Res Clin Pract (1992) 0.80
Effect of adrenocortical hormones on activity of the serotoninergic system in limbic structures in rats. Neuroendocrinology (1975) 0.79
Apoptosis in human ejaculated spermatozoa. J Biol Regul Homeost Agents (2004) 0.79
The effect of hypothalamic serotonin on compensatory adrenal function. Acta Physiol Acad Sci Hung (1973) 0.79
Hypothalamic deafferentation in the rat appears to discriminate between the anterior lobe and intermediate lobe response to stress. Neurosci Lett (1981) 0.79
Apolipoprotein E genotyping in patients with neurodegenerative diseases. Clin Biochem (1997) 0.79
Analysis of the balance between proliferation and apoptosis of cultured vascular smooth muscle cells for tissue-engineering applications. Tissue Eng (2006) 0.79
Action of androgenic steroids on brain neurotransmitters in rats. Neuroendocrinology (1979) 0.79
In vitro effects of estradiol, dydrogesterone, tamoxifen and cyclophosphamide on proliferation vs. death in human breast cancer cells. Cancer Lett (2003) 0.78
Effects of drugs on brain neurotransmitter and pituitary-testicular function in male rats. Horm Res (1979) 0.78
Mapping of CRF-immunoreactive nerve fibers in the medulla oblongata and spinal cord of the rat. Brain Res (1983) 0.78
The effect of continuous combined 17beta-oestradiol and dihydrodydrogesterone on apoptotic cell death and proliferation of human breast cancer cells in vitro. Eur J Cancer (2002) 0.78
Effect of intraventricular injection and intrahypothalamic implantation of serotonin on the hypothalamo-hypophyseal-adrenal system in the rat. Acta Physiol Acad Sci Hung (1972) 0.77
Effects of hypophysectomy, adrenalectomy and corticosterone treatment on uptake and release of putative central neurotransmitters by rat hypothalamic tissue in vitro. Life Sci (1976) 0.77
Ex vivo evidence of lymphocyte apoptosis in hairy cell leukemia, induced by 2-chlorodeoxyadenosine treatment. Ann Hematol (1998) 0.77
Response to "The efficacy of simvastatin is not influenced by CYP2D6 polymorphism" by Geisel et al. Clin Pharmacol Ther (2003) 0.77
Beta3-adrenergic receptor polymorphism and the antiretroviral therapy-related lipodystrophy syndrome. AIDS (2000) 0.77
Induction of apoptosis by heat and gamma-radiation in a human lymphoid cell line; role of mitochondrial changes and caspase activation. Int J Hyperthermia (2006) 0.77
Urinary albumin excretion rate during angiotensin II infusion in microalbuminuric patients with insulin and non-insulin-dependent diabetes mellitus. Nephrol Dial Transplant (1997) 0.77
Differential effects of various opioid peptides on vasopressin and oxytocin release from the rat pituitary in vitro. Naunyn Schmiedebergs Arch Pharmacol (1984) 0.77
A novel time resolved fluorometric assay of anoikis using Europium-labelled Annexin V in cultured adherent cells. Apoptosis (2005) 0.76
Hypo-osmotic swelling test: a reliable screening assay for routine semen specimen quality screening. J Clin Lab Anal (1996) 0.76
[Calprotectin: a fecal marker for diagnosis and follow-up in patients with chronic inflammatory bowel disease]. Ned Tijdschr Geneeskd (2003) 0.76
Neurogenetic correlates of Parkinson's disease: apolipoprotein-E and cytochrome P450 2D6 genetic polymorphism. Neurosci Lett (1999) 0.76
The short Synacthen test: with 1 microgram or 250 micrograms ACTH? Ann Clin Biochem (1997) 0.76
Effects of fulvestrant alone or combined with different steroids in human breast cancer cells in vitro. Climacteric (2008) 0.76
Apoptosis inducers endotoxin and Fas-ligation enhance the expression of vascular endothelial growth factor in human endothelial cells. Endothelium (1999) 0.75
Effect of midbrain raphe lesion on diurnal and stress-induced changes in serotonin content of discrete regions of the limbic system and in adrenal function in the rat. Acta Physiol Acad Sci Hung (1974) 0.75
In vitro release of LHRH from the hypothalamus of female rats during prepubertal development. Neuroendocrinology (1982) 0.75
Relative eosinophilia (Thorn test) as a bioassay to judge the clinical relevance of cortisol values during severe stress. J Clin Endocrinol Metab (1999) 0.75
[Carbohydrate deficient transferrin: a new biochemical marker for chronic, excessive alcohol abuse]. Ned Tijdschr Geneeskd (1997) 0.75
Elevated plasma levels of endothelin are associated with the severity of sepsis and presence of shock in contrast to the levels of atrial natriuretic peptide. Mediators Inflamm (1992) 0.75
Cancer risk in users of calcium channel blockers. Hypertension (1997) 0.75
Lowering caveolin-1 expression in human vascular endothelial cells inhibits signal transduction in response to shear stress. Int J Cell Biol (2008) 0.75
Apoptotic cell death, detected ex vivo in peripheral blood lymphocytes of HIV-1 infected persons. Mediators Inflamm (1996) 0.75
[Immunology in medical practice. VII. Psoriasis]. Ned Tijdschr Geneeskd (1998) 0.75
[Cushing's syndrome: new diagnostic developments and new treatments]. Ned Tijdschr Geneeskd (2007) 0.75
Study of the effects of neurotransmitters on the hypothalamus-pituitary-testis function in in vitro cell suspension system. Arch Androl (1979) 0.75
Analytical and clinical evaluation of three sensitive thyrotropin assays. Ann Clin Biochem (1989) 0.75
[Serum fructosamine levels: an alternative measurement to the percentage glycosylated hemoglobin as a control measure for diabetes]. Ned Tijdschr Geneeskd (1986) 0.75
Diagnostic performance of a modified free-thyroxin assay in subjects with anomalies in their binding proteins. Clin Chem (1989) 0.75
Epinephrine as a potent releaser of immunoreactive beta-endorphin in rats. Eur J Pharmacol (1981) 0.75
Release of beta-lipotropin and beta-endorphin from rat hypothalami in vitro. Brain Res (1981) 0.75
In vitro effects of a synethetic enkephalin analogue (D-Met2,Pro5)-enkephalinamide on the hypothalamus-pituitary--testis function in rats. Neurosci Lett (1979) 0.75
Dopamine inhibits the release of immunoreactive beta-endorphin from rat hypothalamus in vitro. Brain Res (1985) 0.75
[Starting of labor and fetomaternal cortisol production]. Orv Hetil (1980) 0.75
Effect of prostaglandins on hypothalamic-pituitary-testicular function in vitro. Acta Physiol Acad Sci Hung (1979) 0.75
Vasopressin is not involved in the catecholamine-induced release of ACTH, alpha-MSH and beta-endorphin from the rat pituitary gland. Neuroendocrinology (1983) 0.75
Changes of maternal and fetal pituitary-adrenocortical functions during human labour. Horm Res (1979) 0.75
Immunoreactive beta-endorphin in the hypothalamus of female rats: changes in content and release during prepubertal development. Brain Res (1982) 0.75
Flow cytometric analysis of the uptake of low-density lipoprotein by endothelial cells in microfluidic channels. Cytometry A (2010) 0.75
Technique for study of hypothalamus (-) pituitary (-) testis function in vitro. Endocrinol Exp (1979) 0.75
Opposite effects of K+-induced depolarisation on endorphin/lipotropin secretion by anterior and intermediate lobes of the rat pituitary. Eur J Pharmacol (1980) 0.75